Company intelligence / Profile preview

ibidi

Gräfelfing/Martinsried/Planegg, Bavaria, Germanyibidi.com ↗

Ownership: Private
Development stage: Commercial

Overview

ibidi develops advanced products enabling standardized and reproducible functional cell-based assays and high-content cellular microscopy. Their technologies are widely cited in scientific literature (>46,000 publications), supporting breakthroughs in life sciences by facilitating the study of living cells relevant to disease mechanisms such as cancer and cardiovascular conditions.

Modalities: DeviceLabwareCell-based assay platform (not therapeutic drugs)
Industry: Pathology

Partnerships

No major pharmaceutical or biotech partnerships specifically listed; works with global distribution partners.

Beyond the preview

Go deeper on ibidi.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ibidi.

Explore the full profile